|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
99 Park Dr,, Milton, Oxfordshire OX14 4RR, GB
|
|
Grey Wolf Therapeutics is a UK-based drug discovery biotechnology company focused on immuno-oncology and founded by experienced industry professionals Tom McCarthy (Executive Chairman), former President and CEO of Spinifex Pharmaceuticals and Peter Joyce (CEO), formerly of Vertex Pharmaceuticals.
Rather than targeting the immune system, Grey Wolf’s approach is to directly alter the tumour cells, illuminating them for attack and destruction by the immune system. We are targeting a key protein in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells, thus dramatically increasing tumour visibility and extending the reach of immunotherapy in oncology.
Grey Wolf is working with leading academic and commercial drug discovery partners to deliver a clinical candidate against a strongly validated target. The Grey Wolf team is made up of experts in immuno-oncology, antigen presentation and drug discovery.
For more information, visit the website or email [email protected].
|
Grey Wolf Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Grey Wolf Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Grey Wolf Therapeutics customer service number in your country click here to find.
Peter Joyce is the CEO of Grey Wolf Therapeutics. To contact Peter Joyce email at [email protected], [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.